The complement cascade in lung injury and disease
Respiratory Research,
Journal Year:
2024,
Volume and Issue:
25(1)
Published: Jan. 4, 2024
Abstract
Background
The
complement
system
is
an
important
arm
of
immune
defense
bringing
innate
and
adaptive
immunity.
Although
originally
regarded
as
a
major
complementary
mechanism
against
pathogens,
continuously
emerging
evidence
has
uncovered
central
role
this
complex
in
several
diseases
including
lung
pathologies.
Main
body
Complement
factors
such
anaphylatoxins
C3a
C5a,
their
receptors
C3aR,
C5aR
C5aR2
well
inhibitory
proteins
CD55,
CD46
CD59
have
been
implicated
pathologies
the
acute
respiratory
distress
syndrome,
pneumonia,
chronic
obstructive
pulmonary
disease,
asthma,
interstitial
diseases,
cancer.
However,
exact
mechanisms
by
which
induce
these
remain
unclear.
Several
complement-targeting
monoclonal
antibodies
are
reported
to
treat
diseases.
Conclusions
contributes
progression
Better
understanding
underlying
will
provide
groundwork
develop
new
strategy
target
for
treatment
Language: Английский
Emerging role of complement in COVID-19 and other respiratory virus diseases
Cellular and Molecular Life Sciences,
Journal Year:
2024,
Volume and Issue:
81(1)
Published: Feb. 18, 2024
Abstract
The
complement
system,
a
key
component
of
innate
immunity,
provides
the
first
line
defense
against
bacterial
infection;
however,
COVID-19
pandemic
has
revealed
that
it
may
also
engender
severe
complications
in
context
viral
respiratory
disease.
Here,
we
review
mechanisms
activation
and
regulation
explore
their
roles
both
protecting
infection
exacerbating
We
discuss
emerging
evidence
related
to
complement-targeted
therapeutics
compare
role
other
diseases
like
influenza
syncytial
virus.
recent
mechanistic
studies
animal
models
can
be
used
for
further
investigation.
Novel
knockout
are
proposed
better
understand
nuances
system
diseases.
Language: Английский
Complement C1q is involved in the activation of membrane attack complexes, regulation of bacterial infectious inflammation, and apoptosis through overexpression in primary cells of silver pomfret (Pampus argenteus) in vitro
International Journal of Biological Macromolecules,
Journal Year:
2024,
Volume and Issue:
268, P. 131863 - 131863
Published: April 24, 2024
Language: Английский
Complement activity and autophagy are dysregulated in the lungs of patients with nonresolvable COVID-19 requiring lung transplantation
Pooja Shivshankar,
No information about this author
Stacey L. Mueller‐Ortiz,
No information about this author
Aleksey Y. Domozhirov
No information about this author
et al.
Respiratory Research,
Journal Year:
2025,
Volume and Issue:
26(1)
Published: Feb. 27, 2025
The
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)-induced
disease
2019
(COVID-19)
pandemic
has
challenged
the
current
understanding
of
complement
cascade
mechanisms
host
immune
responses
during
infection-induced
nonresolvable
lung
disease.
While
system
is
involved
in
opsonization
and
phagocytosis
invading
pathogens,
uncontrolled
activation
also
leads
to
aberrant
autophagic
response
tissue
damage.
Our
recent
study
revealed
unique
pathologic
fibrotic
signature
genes
associated
with
epithelial
bronchiolization
tissues
patients
COVID-19
(NR-COVID-19)
requiring
transplantation.
However,
there
a
knowledge
gap
if
components
are
modulated
contribute
damage
phenotype
NR-COVID-19.
We,
therefore,
aimed
role
factors
their
corresponding
regulatory
proteins
pathogenesis
We
further
examined
association
mediators
response.
observed
significant
upregulation
expression
classical
pathway
factor
C1qrs
alternative
C3
C5a,
as
well
anaphylatoxin
receptor
C5aR1,
NR-COVID-19
tissues.
Of
note,
protein,
decay
accelerating
(DAF;
CD55)
was
significantly
downregulated
at
both
transcript
protein
levels
lungs,
indicating
dampened
protective
Furthermore,
we
decreased
autophagy
PPARγ
LC3a/b,
which
corroborated
by
P
C3b
CR1,
impaired
clearance
damaged
cells
that
may
patients.
Thus,
our
previously
unrecognized
dysregulation
cell
death
cells,
promote
patients,
ultimately
necessitating
identified
network
dysregulated
activity
indicates
interplay
receptor-mediated
modulation
potential
therapeutic
targets
for
treating
Language: Английский
Human Complement Inhibits Myophages against Pseudomonas aeruginosa
Julia E. Egido,
No information about this author
S. Dekker,
No information about this author
Catherine Toner-Bartelds
No information about this author
et al.
Viruses,
Journal Year:
2023,
Volume and Issue:
15(11), P. 2211 - 2211
Published: Nov. 3, 2023
Therapeutic
bacteriophages
(phages)
are
primarily
chosen
based
on
their
in
vitro
bacteriolytic
activity.
Although
anti-phage
antibodies
known
to
inhibit
phage
infection,
the
influence
of
other
immune
system
components
is
less
well
known.
An
important
anti-bacterial
and
anti-viral
innate
that
may
interact
with
phages
complement
system,
a
cascade
proteases
recognizes
targets
invading
microorganisms.
In
this
research,
we
aimed
study
effects
serum
such
as
infectivity
different
targeting
Pseudomonas
aeruginosa.
We
used
fluorescence-based
assay
monitor
killing
P.
aeruginosa
by
morphotypes
presence
human
serum.
Our
results
reveal
several
myophages
inhibited
concentration-dependent
way,
while
activity
four
podophages
one
siphophage
tested
not
affected
By
using
specific
nanobodies
blocking
cascade,
showed
activation
classical
pathway
driver
inhibition.
To
determine
mechanism
inhibition,
produced
bioorthogonally
labeled
fluorescent
binding
means
microscopy
flow
cytometry.
show
adsorption
hampered
active
complement.
indicate
interactions
affect
vivo
therapeutically
administered
phages.
A
better
understanding
phenomenon
essential
optimize
design
application
therapeutic
cocktails.
Language: Английский
The Complement System and C4b-Binding Protein: A Focus on the Promise of C4BPα as a Biomarker to Predict Clopidogrel Resistance
Molecular Diagnosis & Therapy,
Journal Year:
2024,
Volume and Issue:
28(2), P. 189 - 199
Published: Jan. 23, 2024
Language: Английский
Human Complement Inhibits Myophages against <em>Pseudomonas aeruginosa</em>
Julia E. Egido,
No information about this author
S. Dekker,
No information about this author
Catherine Toner-Bartelds
No information about this author
et al.
Published: Sept. 30, 2023
Therapeutic
phages
are
primarily
chosen
based
on
their
in
vitro
bacteriolytic
activity.
Although
anti-phage
antibodies
known
to
inhibit
phage
infection,
the
influence
of
other
immune
system
components
is
less
well
known.
An
important
anti-bacterial
and
anti-viral
innate
that
may
interact
with
complement
system,
a
cascade
proteases
recognizes
targets
invading
microorganisms.
In
this
study,
we
aimed
study
effects
serum
such
as
infectivity
different
targeting
Pseudomonas
aeruginosa.
We
used
fluorescence-based
assay
monitor
killing
P.
aeruginosa
by
morphotypes
presence
human
serum.
Our
results
reveal
several
myophages
inhibited
concentration-dependent
way,
while
activity
four
podophages
one
siphophage
tested
not
affected
By
using
specific
nanobodies
blocking
cascade,
show
activation
classical
pathway
driver
inhibition.
To
determine
mechanism
inhibition,
produced
bioorthogonally
labeled
fluorescent
binding
means
microscopy
flow
cytometry.
adsorption
hampered
active
complement.
indicate
interactions
affect
vivo
therapeutically
administered
phages.
A
better
understanding
phenomenon
essential
optimize
design
application
therapeutic
cocktails.
Language: Английский
Editorial for SARS-CoV-2 and COVID-19 Topical Collection
Viruses,
Journal Year:
2024,
Volume and Issue:
16(3), P. 356 - 356
Published: Feb. 25, 2024
A
previously
unknown
coronavirus,
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
was
isolated
in
Wuhan,
China
December
2019,
from
a
patient
with
disease
linked
to
potential
contact
wild
animals
[...]
Language: Английский
Human complement Factor H and Properdin act as soluble pattern recognition receptors and differentially modulate SARS-CoV-2 Infection
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: July 8, 2023
Abstract
Severe
cases
of
SARS-CoV-2
infection
are
characterised
by
an
imbalanced
immune
response,
excessive
inflammation,
and
the
development
acute
respiratory
distress
syndrome,
which
can
lead
to
multiorgan
failure
death.
Several
studies
have
demonstrated
dysregulated
complement
activity
as
indicator
immunopathogenesis
in
infection.
Notably,
alternative
pathway
has
been
implicated
driving
inflammation
during
severe
Reduced
levels
factor
H
(FH),
a
down-regulator
pathway,
increased
properdin
(Factor
P/FP),
only
known
up-regulator
observed
individuals
with
COVID-19
The
present
study
investigated
activation-independent,
more
direct
role
FH
FP
against
Using
ELISA,
interactions
spike
(S)
receptor
binding
domain
(RBD)
were
assessed.
S
protein
expressing
lentiviral
pseudotypes,
cell
luciferase-based
virus
entry
assays
employed
assess
potential
modulatory
effects
FH,
FP,
recombinant
thrombospondin
repeats
4
5
(TSR4+5)
on
entry.
We
also
evaluated
immunomodulatory
functions
cytokine
response
triggered
pseudotypes
via
RT-qPCR.
RBD
proteins
found
bind
both
FP.
Treatment
A549
cells
human
ACE2
TMPRSS2
or
TSR4+5
resulted
pseudotypes.
In
silico
revealed
that
increases
affinity
between
host
ACE2.
impact
viral
was
reversed
anti-FP
antibody
treatment
A549-hACE2+TMPRSS2
cells.
However,
reduced
Furthermore,
challenged
spike,
envelope,
nucleoprotein,
membrane
alphaviral
pre-treated
TSR4+5,
exhibited
upregulation
transcripts
pro-inflammatory
cytokines,
such
IL-1β,
IL-8,
IL-6,
TNF-α,
IFN-α
RANTES
(as
well
NF-κB).
Conversely,
pre-treatment
downregulated
expression
these
cytokines.
protein-mediated
NF-κB
activation,
while
it.
These
findings
suggest
may
act
inhibitor
binding,
thereby
attenuating
infection-associated
inflammatory
activation-independent
manner.
contribute
entry,
exacerbating
response.
That
result
potentially
influencing
severity
Language: Английский